Correlation Between Visa and CanSino Biologics

Can any of the company-specific risk be diversified away by investing in both Visa and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and CanSino Biologics, you can compare the effects of market volatilities on Visa and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and CanSino Biologics.

Diversification Opportunities for Visa and CanSino Biologics

0.62

Correlation Coefficient

Visa  CanSino Biologics

Poor diversification

The 3 months correlation between Visa and CanSino is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of Visa i.e., Visa and CanSino Biologics go up and down completely randomly.

Pair Corralation between Visa and CanSino Biologics

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.24 times more return on investment than CanSino Biologics. However, Visa Class A is 4.24 times less risky than CanSino Biologics. It trades about 0.08 of its potential returns per unit of risk. CanSino Biologics is currently generating about -0.02 per unit of risk. If you would invest  21,701  in Visa Class A on October 10, 2024 and sell it today you would earn a total of  9,466  from holding Visa Class A or generate 43.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Visa Class A  vs.  CanSino Biologics

Visa Class A

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in February 2025.

CanSino Biologics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady fundamental drivers, CanSino Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Visa and CanSino Biologics

The main advantage of trading using opposite Visa and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.

The idea behind Visa Class A and CanSino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..